Cargando…

Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation

Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) are challenged with severe side effects, which are propagated by mucosal barrier disruption, and the related microbial translocation and systemic inflammation. Glucagon-like peptide-1 (GLP-1), a well-known incretin hormone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebbesen, Maria, Kissow, Hannelouise, Hartmann, Bolette, Kielsen, Katrine, Sørensen, Kaspar, Stinson, Sara Elizabeth, Frithioff-Bøjsøe, Christine, Esmann Fonvig, Cilius, Holm, Jens-Christian, Hansen, Torben, Holst, Jens Juul, Müller, Klaus Gottlob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692255/ https://www.ncbi.nlm.nih.gov/pubmed/34956226 http://dx.doi.org/10.3389/fimmu.2021.793588

Ejemplares similares

Intestinal Growth in Glucagon Receptor Knockout Mice Is Not Associated With the Formation of AOM/DSS-Induced Tumors
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice
por: Hytting-Andreasen, Rasmus, et al.
Publicado: (2018)

Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
por: Stinson, Sara E, et al.
Publicado: (2022)

SAT037 Glucagon-like Peptide-1 Receptor Knockout Mice Do Not Compensate For The Lack Of Incretin Action By Increasing Glucose-dependent Insulinotropic Polypeptide Secretion
por: Douglas Galsgaard, Katrine, et al.
Publicado: (2023)

Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease
por: Balk-Møller, Emilie, et al.
Publicado: (2019)

Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents
por: Stinson, Sara E, et al.
Publicado: (2021)

Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents
por: Nielsen, Tenna Ruest Haarmark, et al.
Publicado: (2017)

GLP-1 and Intestinal Diseases
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Subclinical Hypothyroidism in Danish Lean and Obese Children and Adolescents
por: Dahl, Maria, et al.
Publicado: (2017)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

(1)H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents
por: Fonvig, Cilius Esmann, et al.
Publicado: (2015)

Multidisciplinary care of obese children and adolescents for one year reduces ectopic fat content in liver and skeletal muscle
por: Fonvig, Cilius Esmann, et al.
Publicado: (2015)

Effects of a Family-Based Childhood Obesity Treatment Program on Parental Weight Status
por: Trier, Cæcilie, et al.
Publicado: (2016)

Childhood obesity treatment; Effects on BMI SDS, body composition, and fasting plasma lipid concentrations
por: Nielsen, Tenna Ruest Haarmark, et al.
Publicado: (2018)

Possible prediction of obesity‐related liver disease in children and adolescents using indices of body composition
por: Johansen, Magnus Jung, et al.
Publicado: (2022)

Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations
por: Trier, Cæcilie, et al.
Publicado: (2020)

A Previously Undescribed Highly Prevalent Phage Identified in a Danish Enteric Virome Catalog
por: Van Espen, Lore, et al.
Publicado: (2021)

Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men
por: Asmar, Ali, et al.
Publicado: (2017)

Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation
por: Billeschou, Anna, et al.
Publicado: (2021)

Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
por: Holst, Jens Juul
Publicado: (2022)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017)

Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial
por: Brodersen, Katrine, et al.
Publicado: (2022)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
por: Guimarães, Marta, et al.
Publicado: (2015)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Common variants in LEPR, IL6, AMD1, and NAMPT do not associate with risk of juvenile and childhood obesity in Danes: a case–control study
por: Hollensted, Mette, et al.
Publicado: (2015)

Pharmacokinetics of exogenous GIP(1-42) in C57Bl/6 mice; Extremely rapid degradation but marked variation between available assays
por: Boer, Geke Aline, et al.
Publicado: (2021)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism
por: Kjeldsen, Sasha A S, et al.
Publicado: (2021)

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2016)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males
por: Skov, Jeppe, et al.
Publicado: (2014)

Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation
por: Ingham, Anna Cäcilia, et al.
Publicado: (2019)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
por: Lobato, Carolina B., et al.
Publicado: (2020)

P03-12 Falling between two stools: parents' experience of supporting their children with cerebral palsy (GMFCS I-II) living an active life
por: Morley, Sofie, et al.
Publicado: (2022)

P03-11 Talking to Danish children/adolescents living with cerebral palsy and their parents about perceived motivators and barriers for being physically active - a family perspective
por: Morley, Sofie, et al.
Publicado: (2022)

The anorexic hormone Peptide YY(3–36) is rapidly metabolized to inactive Peptide YY(3–34) in vivo
por: Toräng, Signe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_raihqaj7mair95s0pau5lb5j88